Atlas Trials

A Randomized, Two-way, Crossover Study to Estimate the Relative Bioavailability of a Controlled-release Formulation of Oxycodone (40 mg) With Sequestered Naltrexone Compared With Immediate-release Oxycodone Tablets (20 mg) in Healthy Volunteers

Clinical trial NCT01677065 · COMPLETED

Trial details

NCT number
NCT01677065
Sponsor
Pfizer
Status
COMPLETED
Study type
OBSERVATIONAL
Healthy
Start date
2012-09-01
Primary completion
2012-10-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.